These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10567414)

  • 41. ZAP-70 and SLP-76 regulate protein kinase C-theta and NF-kappa B activation in response to engagement of CD3 and CD28.
    Herndon TM; Shan XC; Tsokos GC; Wange RL
    J Immunol; 2001 May; 166(9):5654-64. PubMed ID: 11313406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IkappaB kinases serve as a target of CD28 signaling.
    Harhaj EW; Sun SC
    J Biol Chem; 1998 Sep; 273(39):25185-90. PubMed ID: 9737979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for a role of CD28RE as a response element for distinct mitogenic T cell activation signals.
    Civil A; Geerts M; Aarden LA; Verweij CL
    Eur J Immunol; 1992 Nov; 22(11):3041-3. PubMed ID: 1330579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD28 signaling causes a sustained down-regulation of I kappa B alpha which can be prevented by the immunosuppressant rapamycin.
    Lai JH; Tan TH
    J Biol Chem; 1994 Dec; 269(48):30077-80. PubMed ID: 7982907
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of IFN regulatory factor 4 expression in human T cell leukemia virus-I-transformed T cells.
    Sharma S; Grandvaux N; Mamane Y; Genin P; Azimi N; Waldmann T; Hiscott J
    J Immunol; 2002 Sep; 169(6):3120-30. PubMed ID: 12218129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65.
    Ghosh P; Tan TH; Rice NR; Sica A; Young HA
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1696-700. PubMed ID: 8383323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
    Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel CD28-responsive enhancer activated by CREB/ATF and AP-1 families in the human interleukin-2 receptor alpha-chain locus.
    Yeh JH; Lecine P; Nunes JA; Spicuglia S; Ferrier P; Olive D; Imbert J
    Mol Cell Biol; 2001 Jul; 21(14):4515-27. PubMed ID: 11416131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The physical association of protein kinase C theta with a lipid raft-associated inhibitor of kappa B factor kinase (IKK) complex plays a role in the activation of the NF-kappa B cascade by TCR and CD28.
    Khoshnan A; Bae D; Tindell CA; Nel AE
    J Immunol; 2000 Dec; 165(12):6933-40. PubMed ID: 11120819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional analysis of the proximal CCR5 promoter.
    Liu R; Zhao X; Gurney TA; Landau NR
    AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1509-19. PubMed ID: 9840284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular mechanisms of promoter regulation of the gp34 gene that is trans-activated by an oncoprotein Tax of human T cell leukemia virus type I.
    Ohtani K; Tsujimoto A; Tsukahara T; Numata N; Miura S; Sugamura K; Nakamura M
    J Biol Chem; 1998 Jun; 273(23):14119-29. PubMed ID: 9603911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.
    Griffin BD; Moynagh PN
    Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop.
    Hiscott J; Marois J; Garoufalis J; D'Addario M; Roulston A; Kwan I; Pepin N; Lacoste J; Nguyen H; Bensi G
    Mol Cell Biol; 1993 Oct; 13(10):6231-40. PubMed ID: 8413223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional Incompatibility between the Generic NF-κB Motif and a Subtype-Specific Sp1III Element Drives the Formation of the HIV-1 Subtype C Viral Promoter.
    Verma A; Rajagopalan P; Lotke R; Varghese R; Selvam D; Kundu TK; Ranga U
    J Virol; 2016 Aug; 90(16):7046-7065. PubMed ID: 27194770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter.
    Messner B; Stütz AM; Albrecht B; Peiritsch S; Woisetschläger M
    J Immunol; 1997 Oct; 159(7):3330-7. PubMed ID: 9317131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nuclear factor of activated T cells contributes to the function of the CD28 response region of the granulocyte macrophage-colony stimulating factor promoter.
    Shang C; Attema J; Cakouros D; Cockerill PN; Shannon MF
    Int Immunol; 1999 Dec; 11(12):1945-56. PubMed ID: 10590260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T
    Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. c-Rel is a selective activator of a novel IL-4/CD40 responsive element in the human Ig gamma4 germline promoter.
    Agresti A; Vercelli D
    Mol Immunol; 2002 Mar; 38(11):849-59. PubMed ID: 11922943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NF-kappaB and AP-1 are responsible for inducibility of the IL-6 promoter by ionizing radiation in HeLa cells.
    Beetz A; Peter RU; Oppel T; Kaffenberger W; Rupec RA; Meyer M; van Beuningen D; Kind P; Messer G
    Int J Radiat Biol; 2000 Nov; 76(11):1443-53. PubMed ID: 11098847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes.
    Khoshnan A; Tindell C; Laux I; Bae D; Bennett B; Nel AE
    J Immunol; 2000 Aug; 165(4):1743-54. PubMed ID: 10925251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.